BGB-B2033, a bispecific antibody, targets 4-1BB and GPC3, showing potential in advanced hepatocellular carcinoma (HCC) ...
The U.S. Food and Drug Administration (FDA) has granted fast track designation to muzastotug when used in combination with Keytruda (pembrolizumab) to treat adult patients with microsatellite stable ...
DPTX3186 targets the Wnt/β-catenin pathway, crucial in gastric cancer, by forming drug-induced condensates to modulate β-catenin activity. Fast track designation accelerates development and review, ...
InvestorsHub on MSN
Adagene shares jump after FDA awards fast track status to cancer treatment
Shares of Adagene Inc. (NASDAQ:ADAG) jumped more than 16% in pre-market trading on Tuesday after the biotech company said the ...
Shares of microcap biotech Invivyd (IVVD) moved higher in the premarket on Tuesday after the Waltham, Massachusetts-headquartered company announced the FDA’s Fast Track designation for its ...
Among the 10 patients with CCNE1-amplified high grade serous ovarian cancer treated with INX-315, 20% achieved a partial response and 80% achieved stable disease. The Food and Drug Administration (FDA ...
Findings from a phase 2b study showed participants treated with PP-01 had a statistically significant reduction in cannabis withdrawal symptoms compared with placebo. The Food and Drug Administration ...
Amylyx Pharmaceuticals (NASDAQ:AMLX) said on Tuesday that the U.S. FDA has granted fast track status to its antisense RNA, AMX0114, as a treatment for amyotrophic lateral sclerosis, a neurological ...
Johnson & Johnson (NYSE:JNJ) said on Tuesday that it received U.S. FDA's Fast Track designation for nipocalimab to treat adult patients with moderate-to-severe Sjögren's disease. In November last year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results